Request Deal Involvement

Biogen completed the acquisition of Reata Pharmaceuticals for $7.3bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Goldman Sachs

financial advisors

Goldman Sachs

Vinson & Elkins

legal advisors

Vinson & Elkins

Skadden Arps Slate Meagher & Flom

legal advisors to financial advisors

Skadden Arps Slate Meagher & Flom

Lazard

financial advisors

Lazard

Cravath Swaine & Moore

legal advisors

Cravath Swaine & Moore

Simpson Thacher & Bartlett

legal advisors to debt providers

Simpson Thacher & Bartlett

JP Morgan

debt providers

JP Morgan

or

Principals

REATA PHARMACEUTICALS INC

target

REATA PHARMACEUTICALS INC

BIOGEN INC

bidder

BIOGEN INC

SANOFI SA

underbidder

SANOFI SA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite